GOLDSTEIN DOV A MD (Chief Financial Officer) sold 54.6% of their position (27K shares) of BIOAGE LABS, INC. on the open market
Open‑market sale worth $531.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+27K
Price / share
$8.39
Trade value
$226.53K
% of position
Common Stock
Shares
−8.97K
Price / share
$18.43
Trade value
$165.37K
% of position
Common Stock
Shares
−4.44K
Price / share
$19.45
Trade value
$86.37K
% of position
Common Stock
Shares
−11.66K
Price / share
$20.54
Trade value
$239.55K
% of position
Common Stock
Shares
−1.92K
Price / share
$21.08
Trade value
$40.54K
% of position
Net shares
+0.00
Net value
-$305.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2026 | M · Option Exercise | +27K | $8.39 | $226.53K | 120.5% | 22.41K | 49.41K |
| Common Stock Direct | 1/13/2026 | S · Sale | −8.97K | $18.43 | $165.37K | 18.2% | 49.41K | 40.43K |
| Common Stock Direct | 1/13/2026 | S · Sale | −4.44K | $19.45 | $86.37K | 11.0% | 40.43K | 35.99K |
| Common Stock Direct | 1/13/2026 | S · Sale | −11.66K | $20.54 | $239.55K | 32.4% | 35.99K | 24.33K |
| Common Stock Direct | 1/13/2026 | S · Sale | −1.92K | $21.08 | $40.54K | 7.9% | 24.33K | 22.41K |
| Total | +0.00 | -$305.30K | ||||||
Stock Option (Right to Buy)
Common Stock
27K shares
Shares
−27K
Strike price
8.39
Held after
92.59K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock27K shares | 1/13/2026 | M · Option Exercise | −27K | 8.39 | — | 92.59K |